Your browser doesn't support javascript.
loading
There is no market for new antibiotics: this allows an open approach to research and development.
Klug, Dana M; Idiris, Fahima I M; Blaskovich, Mark A T; von Delft, Frank; Dowson, Christopher G; Kirchhelle, Claas; Roberts, Adam P; Singer, Andrew C; Todd, Matthew H.
Afiliação
  • Klug DM; School of Pharmacy, University College London, London, WC1N 1AX, UK.
  • Idiris FIM; School of Pharmacy, University College London, London, WC1N 1AX, UK.
  • Blaskovich MAT; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Lucia, Queensland, 4072, Australia.
  • von Delft F; Centre for Medicines Discovery, The University of Oxford, Oxford, OX3 7DQ, UK.
  • Dowson CG; Diamond Light Source Ltd, Didcot, OX11 0QX, UK.
  • Kirchhelle C; Department of Biochemistry, University of Johannesburg, Auckland Park, 2006, South Africa.
  • Roberts AP; School of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK.
  • Singer AC; School of History, University College Dublin, Dublin, Ireland.
  • Todd MH; Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK.
Wellcome Open Res ; 6: 146, 2021.
Article em En | MEDLINE | ID: mdl-34250265

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article